CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care? Xu B, Fan Y. Lancet Oncol 2021 Jan 15. pii: S1470-2045(20)30757.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu B, Fan Y. CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care? Lancet Oncol 2021 Jan 15. pii: S1470-2045(20)30757.
PMID: 33460573